We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF
LDRS

Delisted

LDRS was delisted on the 13th of August, 2021.

Back to rankings

4 hedge funds and large institutions have $1.11M invested in Innovator IBD ETF Leaders ETF in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more capital invested

Capital invested by funds: $546K → $1.11M (+$569K)

20% less funds holding

Funds holding: 5 → 4 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$969K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$406K
2
UBS Group
UBS Group
Switzerland
-$54.4K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$24K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1.04M +$969K +36,204 New
Osaic Holdings
2
Osaic Holdings
Arizona
$69K – – –
UBS Group
3
UBS Group
Switzerland
$10K -$54.4K -2,031 -85%
Citadel Advisors
4
Citadel Advisors
Florida
– -$406K -16,820 Closed
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
– -$24K -1,000 Closed

LDRS Hedge Fund Activity: Q4 2020 in Review

4 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q4 2020, worth a combined $1.11M — up 104% from $546K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of LDRS and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $969K. The largest seller was Citadel Advisors, exiting entirely with an estimated $406K sold.

  • 4 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q4 2020, down from 5 in Q3 2020.
  • Funds reported $1.11M of Innovator IBD ETF Leaders ETF stock for Q4 2020, up 104% quarter-over-quarter.
  • 1 fund opened new Innovator IBD ETF Leaders ETF positions in Q4 2020 and 2 closed out, a net change of -1 holder.
  • The largest Innovator IBD ETF Leaders ETF buyer in Q4 2020 was Susquehanna International Group, an estimated $969K added.
  • The largest Innovator IBD ETF Leaders ETF seller in Q4 2020 was Citadel Advisors, an estimated $406K sold.

Based on aggregated 13F filings for Q4 2020.